Company Search:
Advanced Search
Sponsored Links
Senomyx, Inc. Company Snapshot
Senomyx, Inc. operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Senomyx with three other companies in this sector in the United States: AC Immune SA (2016 sales of $23.48 million of which 100% was Pharmaceutical), Kite Pharma Inc ($22.17 million of which 100% was Pharmaceutical), and Seres Therapeutics Inc ($21.77 million of which 100% was Pharmaceutical).

Sales Analysis. During the year ended December of 2016, sales at Senomyx were $23.04 million. This is a decrease of 7.4% versus 2015, when the company's sales were $24.88 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Senomyx, Inc.
  Stock Performance Chart for Senomyx, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 1.40
(Figures in U.S. Dollars)
1 Week -2.4%   13 Weeks -4.1%  
4 Weeks 70.3%   52 Weeks 15.7%  
Senomyx, Inc. Key Data:
  Ticker: SNMX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 23,039,000
(Year Ending Jan 2017).
Employees: 59
  Currency: U.S. Dollars Market Cap: 66,901,510
  Fiscal Yr Ends: December Shares Outstanding: 47,786,793
  Share Type: Common Closely Held Shares: 1,092,554
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.